Excipients for Conventional Oral Solid Dosage Forms

Pharmaceutical Excipients: Properties, Functionality, and Applications in Research and Industry

Volumn , Issue , 2016, Pages 51-95

  Kestur, Umesh ^a   Desai, Divyakant ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Coated tablets; Crospovidone; Oral solid dosage forms; Pharmaceutical excipients; Polyethylene glycol; Stearic acid

Indexed keywords

POLYETHYLENE GLYCOLS; POLYETHYLENES; STEARIC ACID;

COATED TABLETS; CROSPOVIDONE; INTEGRAL PART; LOW MELTING POINT; PHARMACEUTICAL EXCIPIENT; POWDER FORMULATIONS; PROCESSABILITY; SOLID DOSAGE FORMS;

SOLID LUBRICANTS;

EID: 85017468827     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118992432.ch2     Document Type: Chapter

References (180)

1. Reier, G.E. and Shangraw, R.F. (1966) Microcrystalline cellulose in tableting. Journal of Pharmaceutical Sciences, 55 (5), 510-514.
2. Lerk, C., Bolhuis, G., and De Boer, A. (1979) Effect of microcrystalline cellulose on liquid penetration in and disintegration of directly compressed tablets. Journal of Pharmaceutical Sciences, 68 (2), 205-211.
3. Jivraj, M., Martini, L.G., and Thomson, C.M. (2000) An overview of the different excipients useful for the direct compression of tablets. Pharmaceutical Science & Technology Today, 3 (2), 58-63.
4. Gissinger, D. and Stamm, A. (1980) A comparative evaluation of the properties of some tablet disintegrants. Drug Development and Industrial Pharmacy, 6 (5), 511-536.
5. Bolhuis, G.K. and Chowhan, Z.T. (1996) Materials for direct compaction. Drugs and the Pharmaceutical Sciences, 71, 419-500.
6. David, S. and Augsburger, L. (1977) Plastic flow during compression of directly compressible fillers and its effect on tablet strength. Journal of Pharmaceutical Sciences, 66 (2), 155-159.
7. Hiestand, E., Wells, J., Peot, C., and Ochs, J. (1977) Physical processes of tableting. Journal of Pharmaceutical Sciences, 66 (4), 510-519.
8. Staniforth, J.N., Baichwal, A.R., Hart, J.P., and Heng, P.W. (1988) Effect of addition of water on the rheological and mechanical properties of microcrystalline celluloses. International Journal of Pharmaceutics, 41 (3), 231-236.
9. Westermarck, S., Juppo, A.M., Kervinen, L., and Yliruusi, J. (1999) Microcrystalline cellulose and its microstructure in pharmaceutical processing. European Journal of Pharmaceutics and Biopharmaceutics, 48 (3), 199-206.
10. Buckton, G., Yonemochi, E., Yoon, W.L., and Moffat, A.C. (1999) Water sorption and near IR spectroscopy to study the differences between microcrystalline cellulose and silicified microcrystalline cellulose before and after wet granulation. International Journal of Pharmaceutics, 181 (1), 41-47.
11. Sun, C.C. (2008) Mechanism of moisture induced variations in true density and compaction properties of microcrystalline cellulose. International Journal of Pharmaceutics, 346 (1), 93-101.
12. Van der Watt, J. (1987) The effect of the particle size of microcrystalline cellulose on tablet properties in mixtures with magnesium stearate. International Journal of Pharmaceutics, 36 (1), 51-54.
13. Pingali, K., Mendez, R., Lewis, D. et al. (2011) Mixing order of glidant and lubricant - Influence on powder and tablet properties. International Journal of Pharmaceutics, 409 (1-2), 269-277.
14. Rowe, R. (1988) Interactions in the ternary powder system microcrystalline cellulose, magnesium stearate and colloidal silica-a solubility parameter approach. International Journal of Pharmaceutics, 45 (3), 259-261.
15. Roberts, R.J. and Rowe, R.C. (1985) The effect of punch velocity on the compaction of a variety of materials. Journal of Pharmacy and Pharmacology, 37 (6), 377-384.
16. Thoorens, G., Krier, F., Leclercq, B. et al. (2014) Microcrystalline cellulose, a direct compression binder in a quality by design environment - A review. International Journal of Pharmaceutics, 473 (1-2), 64-72.
17. Doldán, C., Souto, C., Concheiro, A. et al. (1995) Dicalcium phosphate dihydrate and anhydrous dicalcium phosphate for direct compression: A comparative study. International Journal of Pharmaceutics, 124 (1), 69-74.
18. Khan, K. and Rooke, D. (1976) Effect of disintegrant type upon the relationship between compressional pressure and dissolution efficiency. Journal of Pharmacy and Pharmacology, 28 (8), 633-636.
19. Van Kamp, H.V., Bolhuis, G.K., Kussendrager, K.D., and Lerk, C.F. (1986) Studies on tableting properties of lactose. IV. Dissolution and disintegration properties of different types of crystalline lactose. International Journal of Pharmaceutics, 28 (2-3), 229-238.
20. Vromans, H., Bolhuis, G.K., Lerk, C.F., and Kussendrager, K.D. (1987) Studies on tableting properties of lactose. VIII. The effect of variations in primary particle size, percentage of amorphous lactose and addition of a disintegrant on the disintegration of spray-dried lactose tablets. International Journal of Pharmaceutics, 39 (3), 201-206.
21. Shangraw, R., Wallace, J.W., and Bowers, F. (1981) Morphology and functionality in tablet excipients for direct compression: Part I. Pharmaceutical Technology, 5 (9), 69-78.
22. Debord, B., Lefebvre, C., Guyot-Hermann, A. et al. (1987) Study of different crystalline forms of mannitol: Comparative behaviour under compression. Drug Development and Industrial Pharmacy, 13 (9-11), 1533-1546.
23. Mihranyan, A., Llagostera, A.P., Karmhag, R. et al. (2004) Moisture sorption by cellulose powders of varying crystallinity. International Journal of Pharmaceutics, 269 (2), 433-442.
24. Kothari, S.H., Kumar, V., and Banker, G.S. (2002) Comparative evaluations of powder and mechanical properties of low crystallinity celluloses, microcrystalline celluloses, and powdered celluloses. International Journal of Pharmaceutics, 232 (1), 69-80.
25. Suzuki, T. and Nakagami, H. (1999) Effect of crystallinity of microcrystalline cellulose on the compactability and dissolution of tablets. European Journal of Pharmaceutics and Biopharmaceutics, 47 (3), 225-230.
26. Vromans, H., Bolhuis, G., Lerk, C. et al. (1987) Studies on tableting properties of lactose. VII. The effect of variations in primary particle size and percentage of amorphous lactose in spray dried lactose products. International Journal of Pharmaceutics, 35 (1), 29-37.
27. Bolhuis, G. and Zuurman, K. (1995) Tableting properties of experimental and commercially available lactose granulations for direct compression. Drug Development and Industrial Pharmacy, 21 (18), 2057-2071.
28. Kushner, J., Langdon, B.A., Hiller, J.I., and Carlson, G.T. (2011) Examining the impact of excipient material property variation on drug product quality attributes: A quality-by-design study for a roller compacted, immediate release tablet. Journal of Pharmaceutical Sciences, 100 (6), 2222-2239.
29. Hlinak, A.J., Kuriyan, K., Morris, K.R. et al. (2006) Understanding critical material properties for solid dosage form design. Journal of Pharmaceutical Innovation, 1 (1), 12-17.
30. Landin, M., Martinez-Pacheco, R., Gomez-Amoza, J. et al. (1993) Effect of country of origin on the properties of microcrystalline cellulose. International Journal of Pharmaceutics, 91 (2), 123-131.
31. Gamble, J. F., Chiu, W.-S., Gray, V. et al. (2010) Investigation into batch-to-batch and intra-vendor variability of lactose anhydrous. Paper presented at the AAPS, New Orleans.
32. Obae, K., Iijima, H., and Imada, K. (1999) Morphological effect of microcrystalline cellulose particles on tablet tensile strength. International Journal of Pharmaceutics, 182 (2), 155-164.
33. Zuurman, K., Riepma, K.A., Bolhuis, G.K. et al. (1994) The relationship between bulk density and compactibility of lactose granulations. International Journal of Pharmaceutics, 102 (1-3), 1-9.
34. Hwang, R.-C. and Peck, G.R. (2001) A systematic evaluation of the compression and tablet characteristics of various types of microcrystalline cellulose. Pharmaceutical Technology, 25 (3), 112-132.
35. Landin, M., Martinez-Pacheco, R., Gomez-Amoza, J. et al. (1993) Effect of batch variation and source of pulp on the properties of microcrystalline cellulose. International Journal of Pharmaceutics, 91 (2), 133-141.
36. Landin, M., Martínez-Pacheco, R., Gómez-Amoza, J. et al. (1993) Influence of micro-crystalline cellulose source and batch variation on the tabletting behaviour and stability of prednisone formulations. International Journal of Pharmaceutics, 91 (2), 143-149.
37. Chamarthy, S.P., Pinal, R., and Carvajal, M.T. (2009) Elucidating raw material variability - Importance of surface properties and functionality in pharmaceutical powders. AAPS PharmSciTech, 10 (3), 780-788.
38. Shlieout, G., Arnold, K., and Müller, G. (2002) Powder and mechanical properties of microcrystalline cellulose with different degrees of polymerization. AAPS PharmSciTech, 3 (2), 45-54.
39. Dybowski, U. (1997) Does polymerisation degree matter? Manufacturing Chemist, 68 (12), 19-21.
40. Sakr, A., Elsabbagh, H., and Emara, K. (1974) Sta-Rx 1500 starch: A new vehicle for the direct compression of tablets. Arch. Pharm. Chem.(Sci), 2, 14-24.
41. Bolhuis, G., Lerk, C., Moes, J., and Mulder, C.W.A. (1979) Comparative evaluation of excipients for direct compression. Pharmacy World & Science, 1 (1), 1223-1233.
42. Symecko, C. and Rhodes, C. (1997) The effect of compaction force and type of prege-latinized starch on the dissolution of acetaminophen. Drug Development and Industrial Pharmacy, 23 (3), 229-238.
43. Alebiowu, G. and Itiola, O.A. (2002) Compressional characteristics of native and prege-latinized forms of sorghum, plantain, and corn starches and the mechanical properties of their tablets. Drug Development and Industrial Pharmacy, 28 (6), 663-672.
44. Colorcon. (1997). Starch 1500. Technical Literature.
45. Chowhan, Z. (1980) Role of binders in moisture-induced hardness increase in compressed tablets and its effect on in vitro disintegration and dissolution. Journal of Pharmaceutical Sciences, 69 (1), 1-4.
46. Fitzpatrick, S., McCabe, J.F., Petts, C.R., and Booth, S.W. (2002) Effect of moisture on polyvinylpyrrolidone in accelerated stability testing. International Journal of Pharmaceutics, 246 (1), 143-151.
47. Desai, D., Rubitski, B., Varia, S., and Jain, N. (1996) Povidone-and poloxamer-mediated degradation of hydrochlorothiazide in an antihypertensive combination tablet product. International Journal of Pharmaceutics, 142 (1), 61-66.
48. Guo, J.-H., Skinner, G.W., Harcum, W.W., and Barnum, P.E. (1998) Pharmaceutical applications of naturally occurring water-soluble polymers. Pharmaceutical Science & Technology Today, 1 (6), 254-261.
49. Rowe, R.C., Sheskey, P.J., and Quinn, M.E. (eds) (2009) Handbook of pharmaceutical excipients, Sixth edn, Pharmaceutical Press and American Pharmacists Association, Grayslake, IL and Washington DC.
50. Desai, D., Rinaldi, F., Kothari, S. et al. (2006) Effect of hydroxypropyl cellulose (HPC) on dissolution rate of hydrochlorothiazide tablets. International Journal of Pharmaceutics, 308 (1), 40-45.
51. Tiwari, S.B., Murthy, T.K., Raveendra Pai, M. et al. (2003) Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech, 4 (3), 18-23.
52. Porter, S.C. (1989) Controlled-release film coatings based on ethylcellulose. Drug Development and Industrial Pharmacy, 15 (10), 1495-1521.
53. Desai, R.P., Neau, S.H., Pather, S.I., and Johnston, T.P. (2001) Fine-particle ethylcellu-lose as a tablet binder in direct compression, immediate-release tablets. Drug Development and Industrial Pharmacy, 27 (7), 633-641.
54. Pollock, D., and Balwinski, K. (1997) Aqueous granulation of an ethylcellulose containing inert matrix formulation. Paper presented at the Annual Association of Pharmaceutical Scientist Annual Meeting, Boston, MA.
55. Agrawal, A.M., Neau, S.H., and Bonate, P.L. (2003) Wet granulation fine particle ethyl-cellulose tablets: Effect of production variables and mathematical modeling of drug release. The AAPS Journal, 5 (2), 48-60.
56. Olsson, H., Mattsson, S., and Nyström, C. (1998) Evaluation of the effect of addition of polyethylene glycols of differing molecular weights on the mechanical strength of sodium chloride and sodium bicarbonate tablets. International Journal of Pharmaceutics, 171 (1), 31-44.
57. Desai, D., Rao, V., Guo, H. et al. (2007) Stability of low concentrations of guanine-based antivirals in sucrose or maltitol solutions. International Journal of Pharmaceutics, 342 (1), 87-94.
58. Millili, G.P. and Schwartz, J.B. (1990) The strength of microcrystalline cellulose pellets: The effect of granulating with water/ethanol mixtures. Drug Development and Industrial Pharmacy, 16 (8), 1411-1426.
59. Wikberg, M. and Alderborn, G. (1993) Compression characteristics of granulated materials. VII. The effect of intragranular binder distribution on the compactibility of some lactose granulations. Pharmaceutical Research, 10 (1), 88-94.
60. Parikh, D.M. (ed.) (2005) Handbook of Pharmaceutical Granulation Technology, 2nd edn, Taylor and Francis group, LLC, Boca Raton, FL.
61. Rue, P., Seager, H., Burt, I., Ryder, J., Murray, S., and Beal, N. (1979) The effect of granule structure on the mechanical properties of tablets. Journal of Pharmacy and Pharmacology, 31 (S1), 73 P. doi: 10.1111/j.2042-7158.1979.tb11621.x.
62. Cantor, S.L., Kothari, S., and Koo, O.M.Y. (2009) Evaluation of the physical and mechanical properties of high drug load formulations: Wet granulation vs. novel foam granulation. Powder Technology, 195 (1), 15-24.
63. Becker, D., Rigassi, T., and Bauer-Brandl, A. (1997) Effectiveness of binders in wet granulation: A comparison using model formulations of different tabletability. Drug Development and Industrial Pharmacy, 23 (8), 791-808.
64. Upadrashta, S.M., Katikaneni, P.R., and Nuessle, N.O. (1992) Chitosan as a tablet binder. Drug Development and Industrial Pharmacy, 18 (15), 1701-1708.
65. Itiola, O. and Pilpel, N. (1991) Formulation effects on the mechanical properties of metronidazole tablets. Journal of Pharmacy and Pharmacology, 43 (3), 145-147.
66. Boutell, S., Newton, J., Bloor, J., and Hayes, G. (2002) The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization. International Journal of Pharmaceutics, 238 (1), 61-76.
67. Joneja, S., Harcum, W., Skinner, G. et al. (1999) Investigating the fundamental effects of binders on pharmaceutical tablet performance. Drug Development and Industrial Pharmacy, 25 (10), 1129-1135.
68. Baykara, T. and Acarturk, F. (1989) The effect of the binding agents on the friability and compressibility of granules. Drug Development and Industrial Pharmacy, 15 (9), 1341-1351.
69. Danjo, K., Kozaki, K., Sunada, H., and Otsuka, A. (1994) Influence of the molecular weight of binding agents on the physical properties of granules and tablets. Chemical and Pharmaceutical Bulletin, 42 (10), 2121-2125.
70. Nyström, C., Mazur, J., and Sjögren, J. (1982) Studies on direct compression of tablets. II. The influence of the particle size of a dry binder on the mechanical strength of tablets. International Journal of Pharmaceutics, 10 (3), 209-218.
71. Nyström, C. and Glazer, M. (1985) Studies on direct compression of tablets. XIII. The effect of some dry binders on the tablet strength of compounds with different fragmentation propensity. International Journal of Pharmaceutics, 23 (3), 255-263.
72. Horisawa, E., Komura, A., Danjo, K., and Otsuka, A. (1995) Effect of binder characteristics on the strength of agglomerates prepared by the wet method. II. Chemical and Pharmaceutical Bulletin, 43 (3), 488-492.
73. Rowe, R. (1990) Correlation between predicted binder spreading coefficients and measured granule and tablet properties in the granulation of paracetamol. International Journal of Pharmaceutics, 58 (3), 209-213.
74. Healey, J., Rubinstein, M., and Walters, V. (1974) The mechanical properties of some binders used in tableting. Journal of Pharmacy and Pharmacology, 26 (S1), 41P-46P.
75. Chowhan, Z. and Yang, I.C. (1983) Effect of intergranular versus intragranular cornstarch on tablet friability and in vitro dissolution. Journal of Pharmaceutical Sciences, 72 (9), 983-988.
76. Rudnic, E., Kanig, J., and Rhodes, C. (1985) Effect of molecular structure variation on the disintegrant action of sodium starch glycolate. Journal of Pharmaceutical Sciences, 74 (6), 647-650.
77. Khan, K. and Rhodes, C. (1975) Water sorption properties of tablet disintegrants. Journal of Pharmaceutical Sciences, 64 (3), 447-451.
78. Bolhuis, G.K., Van Kamp, H., Lerk, C. et al. (1984) Effect of variation of degree of substitution, crosslinking and purity on the disintegration efficiency of sodium starch glycolate. Acta Pharmaceutica Technologica, 30 (1), 24-32.
79. Gordon, M., and Chowhan, Z. (1987) Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution. Journal of Pharmaceutical Sciences, 76 (12), 907-909.
80. Gordon, M.S., Rudraraju, V.S., Dani, K., and Chowhan, Z.T. (1993) Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. Journal of Pharmaceutical Sciences, 82 (2), 220-226.
81. Shah, U. and Augsburger, L. (2002) Multiple sources of sodium starch glycolate, NF: Evaluation of functional equivalence and development of standard performance tests. Pharmaceutical Development and Technology, 7 (3), 345-359.
82. Edge, S., Steele, D.F., Staniforth, J.N. et al. (2002) Powder compaction properties of sodium starch glycolate disintegrants. Drug Development and Industrial Pharmacy, 28 (8), 989-999.
83. Sheen, P.-C. and Kim, S.-I. (1989) Comparative study of disintegrating agents in tiaramide hydrochloride tablets. Drug Development and Industrial Pharmacy, 15 (3), 401-414. doi: 10.3109/03639048909040220.
84. Kornblum, S.S. and Stoopak, S.B. (1973) A new tablet disintegrating agent: Crosslinked polyvinylpyrrolidone. Journal of Pharmaceutical Sciences, 62 (1), 43-49.
85. Balasubramaniam, J., Bindu, K., Rao, V., Ray, D., Haldar, R., and Brzeczko, A. (2008) Effect of superdisintegrants on dissolution of cationic drugs. Dissolution Technologies, 15(2), 18-25.
86. Rudnic, E., Lausier, J., Chilamkurti, R., and Rhodes, C. (1980) Studies of the utility of cross linked polyvinlpolypyrrolidine as a ablet disintegrant. Drug Development and Industrial Pharmacy, 6 (3), 291-309.
87. Shah, U. and Augsburger, L. (2001) Evaluation of the functional equivalence of crospovi-done NF from different sources. I. Physical characterization. Pharmaceutical Development and Technology, 6 (1), 39-51.
88. Marais, A.F., Song, M., and De Villiers, M.M. (2005) Effect of compression force, humidity and disintegrant concentration on the disintegration and dissolution of directly compressed furosemide tablets using croscarmellose sodium as disintegrant. Tropical Journal of Pharmaceutical Research, 2 (1), 125-135.
89. Zhao, N. and Augsburger, L. (2006) The influence of product brand-to-brand variability on superdisintegrant performance a case study with croscarmellose sodium. Pharmaceutical Development and Technology, 11 (2), 179-185.
90. Impact of cellulose source on properties and disintegration performance of croscarmel-lose sodium. FMC BioPolymer Technical Bulletin, Accessed online Aug 13 2015 at: http://www.fmcbiopolymer.com/Portals/Pharm/Content/Docs/SDW-802%20Bulletin%2010-13-11.pdf
91. Van Kamp, H., Bolhuis, G., and Lerk, C. (1983) Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation. Pharmacy World & Science, 5 (4), 165-171.
92. Khattab, I., Menon, A., and Sakr, A. (1993) Effect of mode of incorporation of disinte-grants on the characteristics of fluidbed wet granulated tablets. Journal of Pharmacy and Pharmacology, 45 (8), 687-691.
93. Smallenbroek, A., Bolhuis, G., and Lerk, C. (1981) The effect of particle size of disinte-grants on the disintegration of tablets. Pharmacy World & Science, 3 (1), 1048-1051.
94. Swarbrick, J. (ed.) (2007) Encyclopedia of Pharmaceutical Technology, 3rd edn, vol. 6, Informa Healthcare USA, New York.
95. Zhao, N. and Augsburger, L.L. (2006) The influence of granulation on super disintegrant performance. Pharmaceutical Development and Technology, 11 (1), 47-53.
96. Hill, P.M. (1976) Effect of compression force and corn starch on tablet dis-integration time. Journal of Pharmaceutical Sciences, 65 (11), 1694-1697. doi: 10.1002/jps.2600651134.
97. Lowenthal, W. (1972) Disintegration of tablets. Journal of Pharmaceutical Sciences, 61 (11), 1695-1711.
98. Johnson, J.R., Wang, L.H., Gordon, M.S., and Chowhan, Z.T. (1991) Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution. Journal of Pharmaceutical Sciences, 80 (5), 469-471.
99. Chebli, C. and Cartilier, L. (1998) Cross-linked cellulose as a tablet excipient: A bind-ing/disintegrating agent. International Journal of Pharmaceutics, 171 (1), 101-110.
100. Setty, C. M., Prasad, D., Gupta, V., and Sa, B. (2008) Development of fast dispersible aceclofenac tablets: Effect of functionality of superdisintegrants. Indian Journal of Pharmaceutical Sciences, 70 (2), 180-185.
101. Bolhuis, G., Zuurman, K., and Te Wierik, G. (1997) Improvement of dissolution of poorly soluble drugs by solid deposition on a super disintegrant. II. The choice of super disintegrants and effect of granulation. European Journal of Pharmaceutical Sciences, 5 (2), 63-69.
102. Patel, S., Kaushal, A.M., and Bansal, A.K. (2011) The effect of starch paste and sodium starch glycolate on the compaction behavior of wet granulated acetaminophen formulations. Journal of Excipients and Food Chemicals, 2 (3), 64-72.
103. Zhao, N. and Augsburger, L.L. (2005) The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech, 6 (1), 120-126.
104. Chen, C.-R., Lin, Y.-H., Cho, S.-L. et al. (1997) Investigation of the dissolution difference between acidic and neutral media of acetaminophen tablets containing a super disinte-grant and a soluble excipient. Chemical and Pharmaceutical Bulletin, 45 (3), 509-512.
105. Bindra, D., Hsieh, D., Pandey, P., and Barbour, N. (2014) Incompatability of croscarmel-lose with alkaline excipients in a tablet formulation. Pharmaceutical Development and Technology, 19 (3), 285-289.
106. Bolhuis, G., Van Kamp, H., Lerk, C., and Sessink, F. (1982) On the mechanism of action of modern disintegrants. Acta Pharmaceutica Technologies, 28, 111-114.
107. Bolhuis, G.K., Smallenbroek, A.J., and Lerk, C.F. (1981) Interaction of tablet disinte-grants and magnesium stearate during mixing. I. Effect on tablet disintegration. Journal of Pharmaceutical Sciences, 70 (12), 1328-1330. doi: 10.1002/jps.2600701210.
108. Rojas, J., Guisao, S., and Ruge, V. (2012) Functional assessment of four types of disintegrants and their effect on the spironolactone release properties. AAPS PharmSciTech, 13 (4), 1054-1062.
109. Gordon, M.S., Rudraraju, V.S., Rhie, J.K., and Chowhan, Z.T. (1993) The effect of aging on the dissolution of wet granulated tablets containing super disintegrants. International Journal of Pharmaceutics, 97 (1), 119-131.
110. Pourkavoos, N. and Peck, G.E. (1993) The effect of swelling characteristics of superdisintegrants on the aqueous coating solution penetration into the tablet matrix during the film coating process. Pharmaceutical Research, 10 (9), 1363-1371.
111. Hadfield, P., Bayhan, N., Porter, S., and Drefko, W. (2008) An investigation into the effects of increasing the super-disintegrant content in a tablet formulation on the ease of film coating using surface-roughness analysis to evaluate surface effects. Paper presented at the American Association of Pharmaceutical Scientists, Atlanta.
112. Wang, J., Wen, H., and Desai, D. (2010) Lubrications in tablet formulations. European Journal of Pharmaceutics and Biopharmaceutics, 75, 1-15.
113. Miller, T. and York, P. (1988) Pharmaceutical tablet lubrication. International Journal of Pharmaceutics, 41 (1), 1-19.
114. Li, J. and Wu, Y. (2014) Lubricants in pharmaceutical solid dosage forms. Lubricants, 2 (1), 21-43.
115. Garti, N., Wellner, E., and Sarig, S. (1980) Stearic acid polymorphs in correlation with crystallization conditions and solvents. Kristall und Technik, 15 (11), 1303-1310.
116. Swaminathan, V. and Kildsig, D.O. (2001) An examination of the moisture sorption characteristics of commercial magnesium stearate. AAPS PharmSciTech, 2 (4), 1-7.
117. Dansereau, R. and Peck, G.E. (1987) The effect of the variability in the physical and chemical properties of magnesium stearate on the properties of compressed tablets. Drug Development and Industrial Pharmacy, 13 (6), 975-999.
118. Barra, J. and Somma, R. (1996) Influence of the physicochemical variability of magnesium stearate on its lubricant properties: Possible solutions. Drug Development and Industrial Pharmacy, 22 (11), 1105-1120.
119. Kestur, U., Wong, B.L.Z., Tang, D., Sharif, S. Guo, H., Desai, D. (2012) Effect of povi-done concentration on magnesium stearate sensitivity to magnesium stearate. Paper presented at the AAPS annual meeting, Chicago.
120. Rao, K.P., Chawla, G., Kaushal, A.M., and Bansal, A.K. (2005) Impact of solid-state properties on lubrication efficacy of magnesium stearate. Pharmaceutical Development and Technology, 10 (3), 423-437.
121. Ertel, K. and Carstensen, J. (1988) Chemical, physical, and lubricant properties of magnesium stearate. Journal of Pharmaceutical Sciences, 77 (7), 625-629.
122. Narang, A.S., Desai, D., and Badawy, S. (2012) Impact of excipient interactions on solid dosage form stability. Pharmaceutical Research, 29 (10), 2660-2683.
123. Desai, D.S., Rubitski, B.A., Varia, S.A., and Newman, A.W. (1993) Physical interactions of magnesium stearate with starch-derived disintegrants and their effects on capsule and tablet dissolution. International Journal of Pharmaceutics, 91 (2-3), 217-226.
124. Bolhuis, C., Lerk, C., and Broersma, P. (1980) Mixing action and evaluation of tablet lubricants in direct compression. Drug Development and Industrial Pharmacy, 6 (1), 15-33.
125. Bossert, J. and Stains, A. (1980) Effect of mixing on the lubrication of crystalline lactose by magnesium stearate. Drug Development and Industrial Pharmacy, 6 (6), 573-589.
126. Mitrevej, K.T. and Augsburger, L. (1982) Adhesion of tablets in a rotary tablet press. II. Effects of blending time, running time, and lubricant concentration. Drug Development and Industrial Pharmacy, 8 (2), 237-282.
127. Lerk, C., Bolhuis, G., and Smedema, S. (1977) Interaction of lubricants and colloidal silica during mixing with excipients. I. Its effect on tabletting. Pharmaceutica Acta Helvetiae, 52 (3), 33-39.
128. Johansson, M.E. and Nicklasson, M. (1987) Influence of mixing time, particle size, and colloidal silica on the surface coverage and lubrication of magnesium stearate, in Pharmaceutical Technology: Tableting Technology, Halstead Press, New York, pp. 43-50.
129. Desai, D., Kothari, S., Huang, M. (2008) Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules. International Journal of Pharmaceutics, 354, 77-81.
130. Rowe, R. (2007) Film/tablet adhesion, film thickness, internal stresses and bridging of the intagliations - A unified model with practical implications. European Journal of Pharmaceutical Sciences, 30 (3), 236-239.
131. Rowe, R. (1977) The adhesion of film coatings to tablet surfaces-the effect of some direct compression excipients and lubricants. Journal of Pharmacy and Pharmacology, 29 (1), 723-726.
132. Rowe, R. (1983) The coating of tablet surfaces by lubricants as determined by a film/tablet adhesion measurement. Acta Pharmaceutica Suecica, 20 (1), 77-80.
133. Pandey, P., Bindra, D.S., Gour, S. et al. (2014) Excipient-process interactions and their impact on tablet compaction and film coating. Journal of Pharmaceutical Sciences, 103 (11), 3666-3674.
134. Thakur, A.B., Morris, K., Grosso, J.A. et al. (1993) Mechanism and kinetics of metal ion-mediated degradation of fosinopril sodium. Pharmaceutical Research, 10 (6), 800-809.
135. Poznan, S.B. (2005) The influence of pharmaceutical excipients on quinapril hydrochlo-ride stability. Acta Poloniae Pharmaceutica, 62, 189-193.
136. Wang, J., Davidovich, M., Desai, D. et al. (2010) Solid-state interactions of a drug substance and excipients and their impact on tablet dissolution: A thermal-mechanical facilitated process induced transformation or PTI. Journal of Pharmaceutical Sciences, 99 (9), 3849-3862.
137. Kushner, J. and Morre, F. (2010) Scale-up model describing the impact of lubrication on tablet tensile strength. International Journal of Pharmaceutics, 399, 19-30.
138. Roche, E. J. (1991) Taste masking and sustained release coatings for pharmaceuticals. US patent 5,075,114 A.
139. Desai, D., Abdelnasser, M., Rubitski, B., and Varia, S. (1994) Photostabilization of uncoated tablets of sorivudine and nifedipine by incorporation of synthetic iron oxides. International Journal of Pharmaceutics, 103 (1), 69-76.
140. Banker, G.S. (1966) Film coating theory and practice. Journal of Pharmaceutical Sciences, 55 (1), 81-89.
141. Cunningham, C. (2007) Reducing coated tablet defects from laboratory through production scale: Performance of hypromellose or polyvinyl alcohol-based aqueous film coating systems. Paper presented at the Annual Association of Pharmaceutical Scientists, San Diego.
142. Felton, L.A., O'Donnell, P.B., and McGinity, J.W. (2008) Mechanical properties of polymeric films prepared from aqueous dispersions, in Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, 3rd edn (eds L.A. Felton and J.W. McGinity), Informa Healthcare, pp. 105-128.
143. Obara, S. and Kokubo, H. (2008) Application of HPMC and HPMCAS to aqueous film coating of pharmaceutical dosage forms, in Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, 3rd edn (eds L.A. Felton and J.W. McGinity), Informa Healthcare, Boca Raton, FL, pp. 279-322.
144. Rajabi-Siahboomi, A.R. and Farrell, T.P. (2008) The applications of formulated systems for the aqueous film coating of pharmaceutical oral solid dosage forms, in Aqueous Polymeric Coating for Pharmaceutical Dosage Forms, 3rd edn (eds L.A. Felton and J.W. McGinity), Informa Healthcare, Boca Raton, FL Vol. 176, pp. 323-344.
145. Thoma, C., Betchtold K. (2000) Enteric Coated Hard Gelatin Capsules, in Capsugel Library, Capsugel pp. 1-17, Accessed online Aug 13 2015 at: http://owndoc.com/pdf/enteric-coated-hard-gelatin-capsules.pdf.
146. Shukla, A.J. (ed.) (1994) Handbook of Pharmaceutical Excipients, 2nd edn, The Pharmaceutical Press, London.
147. Jenquin, M.R., Sarabia, R.E., Liebowitz, S.M., and McGinity, J.W. (1992) Relationship of film properties to drug release from monolithic films containing adjuvants. Journal of Pharmaceutical Sciences, 81 (10), 983-989.
148. Johson, K., Hathaway, R., Leung, P., and Franz, R. (1991) Effect of triacetin and polyethylene glycol 400 on some physical properties of hydroxypropyl methylcellulose free films. International Journal of Pharmaceutics, 73, 197-208.
149. Felton, L.A. and McGinity, J.W. (2002) Influence of insoluble excipients on film coating systems. Drug Development and Industrial Pharmacy, 28 (3), 225-243.
150. Bechard, S.R., Quraishi, O., and Kwong, E. (1992) Film coating: Effect of titanium dioxide concentration and film thickness on the photostability of nifedipine. International Journal of Pharmaceutics, 87, 133-139.
151. Felton, L.A., Austin-Forbes, T., and Moore, T.A. (2000) Influence of surfactants in aqueous-based polymeric dispersions on the thermomechanical and adhesive properties of acrylic films. Drug Development and Industrial Pharmacy, 26 (2), 205-210.
152. Seitz, J.A., Mehta, S.P., and Yeager, J.L. (eds) (1986) Tablet Coating, 3rd edn, Lea & Febiger, Philadelphia.
153. Allam, K.V. and Kumar, G.P. (2011) The cosmetics for pharmaceutical dosage forms. International Journal of Pharmacy and Pharmaceutical Sciences, 3, 12-21.
154. Swartz, C.J. and Cooper, J. (1962) Colorants for pharmaceuticals. Journal of Pharmaceutical Sciences, 51 (2), 89-99.
155. Cooper, J.W. Jr., Ansel, H.C., and Cadwallader, D.E. (1973) Liquid and solid solution interactions of primary certified colorants with pharmaceutical gelatins. Journal of Pharmaceutical Sciences, 62 (7), 1156-1164.
156. Lobo, M., Patel, J., Kamins, G. et al. (2007) Interactions of omapatrilat with FD&C Blue No. 2 lake during dissolution of modified release tablets. International Journal of Pharmaceutics, 339, 168-174.
157. Badawy, S.I.F. and Hussain, M.A. (2007) Minireview: Microenvironmental pH modulation in solid dosage forms. Journal of Pharmaceutical Sciences, 96 (5), 948-959.
158. Hawley, M. and Morozowich, W. (2010) Modifying the diffusion layer of soluble salts of poorly soluble basic drugs to improve dissolution performance. Molecular Pharmaceutics, 7 (5), 1441-1449.
159. Badawy, S.I.F., Williams, R.C., and Gilbert, D.L. (1999) Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms. Journal of Pharmaceutical Sciences, 88 (4), 428-433.
160. Patel, H., Stalcup, A., Dansereau, R., and Sakr, A. (2003) The effect of excipients on the stability of levothyroxine sodium penta hydrate tablets. International Journal of Pharmaceutics, 264, 35-43.
161. Hailu, S. and Bogner, R. (2009) Effects of pH grade of silicates on chemical stability of coground amorphous quinapril hydrochloride and its stabilization using pH-modifiers. Journal of Pharmaceutical Sciences, 98 (9), 3358-3372.
162. Ploen, J., Andersch, J., Heschel, M., and Leopold, C. (2009) Citric acid as a pH-modifying additive in an extended release pellets formulation containing a weakly basic drug. Drug Development and Industrial Pharmacy, 35 (10), 1210-1218.
163. Thoma, K. and Zimmer, T. (1990) Retardation of weakly basic drugs with diffusion tablets. International Journal of Pharmaceutics, 58, 197-202.
164. Doherty, C. and York, P. (1989) Microenvironmental pH control of drug dissolution. International Journal of Pharmaceutics, 50, 223-232.
165. Tirkkonnen, S., Urtti, A., and Paronen, P. (1995) Buffer controlled release of indomethacin from ethylcellulose microcapsules. International Journal of Pharmaceutics, 124, 219-229.
166. Taniguchi, C., Inoue, R., Kaeabata, Y. et al. (2012) Novel formulations of dipyrimadole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria. International Journal of Pharmaceutics, 434, 148-154.
167. El-Say, K.M., Refaey, T.A., Samy, A.M., and Badawy, A.A. (2010) Comparative study among different techniques to improve the physical and technical properties prevailing to compression of poorly flowing and highly cohesive drug. International Journal of Pharmaceutical Sciences Review and Research, 4, 67-76.
168. Lipasek, R.A., Taylor, L.S., and Mauer, L.J. (2011) Effects of anticaking agents and relative humidity on the physical and chemical stability of powdered vitamin C. Journal of Food Science, 76 (7), C1062-C1074.
169. Wu, Y., Levons, J., Narang, A.S. et al. (2011) Reactive impurities in excipients: Profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech, 12 (4), 1248-1263.
170. Narang, A.S., Rao, V.M., and Desai, D.S. (2012) Effect of antioxidants and silicates on peroxides in povidone. Journal of Pharmaceutical Sciences, 101, 127-139.
171. Nachaegari, S.K. and Bansal, A.K. (2004) Coprocessed excipients for solid dosage forms. Pharmaceutical Technology, 28 (1), 52-65.
172. Moreton, R.C. (1996) Tablet excipients to the year 2001: A look into the crystal ball. Drug Development and Industrial Pharmacy, 22 (1), 11-23.
173. Reimerdes, D. (1993) The near future of tablet excipients. Manufacturing Chemist, 64 (7), 14-15.
174. Khalaf, A., Tobyn, M., and Staniforth, J. (1997) Measurement of the flow properties of silicified microcrystalline cellulose. Paper presented at the Proceedings of the AAPS conference.
175. Staniforth, J. and Chatrath, M. (1996) Towards a new class of high functionality tablet binders. I: Quasi-hornification of microcrystalline cellulose and loss of functionality. Pharmaceutical Research, 13 (9), S208.
176. Tobyn, M.J., McCarthy, G.P., Staniforth, J.N., and Edge, S. (1998) Physico-chemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose. International Journal of Pharmaceutics, 169 (2), 183-194. doi: 10.1016/S0378-5173(98)00127-6
177. IPEC-Americas Co-processed Excipients Workshop. (Apr 29, 2013). Retrieved Oct 2014 http://ipecamericas.org/system/files/coprocessed-excipient-workshop.pdf
178. Erdemir, D., Chang, S. Y., Desai, D., and Kiang, S. (2013, WO2013130785A3).
179. Raghavan, K.S., Ranadive, S.A., Bembenek, K.S. et al. (2003) US6589955 B2US6589955 B2, Google patents.
180. Mohammed, G., Puri, V., and Bansal, A.K. (2008) Coprocessing of nevirapine and stavu-dine by spray drying. Pharmaceutical Development and Technology, 13 (4), 299-310.